Basic immunology of antibody targeted radiotherapy
- 1 October 2006
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 66 (2) , S8-S14
- https://doi.org/10.1016/j.ijrobp.2005.05.056
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Tumor Targeting of Radiometal Labeled Anti-CEA Recombinant T84.66 Diabody and T84.66 Minibody: Comparison to Radioiodinated FragmentsBioconjugate Chemistry, 2001
- Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neuBritish Journal of Cancer, 1998
- A CDR-Grafted (Humanized) Domain-Deleted Antitumor AntibodyCancer Biotherapy & Radiopharmaceuticals, 1997
- Triabodies: single chain Fv fragments without a linker form trivalent trimersFEBS Letters, 1997
- Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimersImmunotechnology, 1996
- Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer.Journal of Clinical Oncology, 1994
- Human Immune Respone to Monoclonal AntibodiesJournal of Immunotherapy, 1994
- Secretion of a single-gene-encoded immunoglobulin from myeloma cells.Proceedings of the National Academy of Sciences, 1993
- Biologic properties of a Ch2 domain‐deleted recombinant immunoglobulinInternational Journal of Cancer, 1993
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975